Synergistic Cytotoxic and Clonogenic Effects of Paclitaxel and Allicin in MDA-MB-231 Triple-Negative Breast Cancer Cells
Background: Triple-negative breast cancer (TNBC) lacks validated molecular targets and relies on cytotoxic chemotherapy limited by toxicity. Combining paclitaxel with the redox-active garlic compound allicin may permit dose reduction while preserving activity. Objective: To define the in vitro cytotoxic profiles of pac...